Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced ...
Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...
On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for ...
The Ghana Food and Drugs Authority (FDA) has spearheaded a joint initiative with National Regulatory Authorities (NRAs) in seven African countries to foster trust, enhance regulatory reliance, and ...
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...
All 12 Quarter Horses have been placed on the Steward's List meaning they cannot run in any licensed jurisdiction in North America until the adjudication process has been finalized. Both trainers were ...